Use of methylnaltrexone for the treatment of opioid induced constipation & gastroIntestinal stasis in intensive care patients

Trial Profile

Use of methylnaltrexone for the treatment of opioid induced constipation & gastroIntestinal stasis in intensive care patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Mar 2017

At a glance

  • Drugs Methylnaltrexone bromide (Primary)
  • Indications Constipation
  • Focus Therapeutic Use
  • Acronyms MOTION
  • Most Recent Events

    • 01 Mar 2017 Status changed from active, no longer recruiting to completed.
    • 01 Sep 2016 Status changed from recruiting to active, no longer recruiting.
    • 10 Dec 2015 Accrual to date is 7% according to against United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top